Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO)
- PMID: 27761611
- DOI: 10.1007/s00066-016-1052-2
Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO)
Abstract
Purpose: To evaluate the outcomes with respect to long-term survival and toxicity in patients with nasopharyngeal carcinoma (NPC) treated in a European country with low incidence.
Materials and methods: A prospective observational study carried out by the AIRO Head and Neck group in 12 Italian institutions included 136 consecutive patients treated with radiotherapy (RT) ± chemotherapy (CHT) for NPC (without distant metastasis) between January 1, 2008 and December 31, 2010.
Results: The disease-specific survival (DSS), overall survival (OS), and disease-free survival (DFS) at 5 years were 92 (±2), 91 (±3), and 69 % (±5 %), respectively. Distant failure was the most frequent modality of relapse. The local, regional, and locoregional control at 5 years were 89 (±3), 93 (±3), and 84 % (±4 %), respectively. The incidence of acute and late toxicity and the correlations with different clinical/technical variables were analyzed. Neoadjuvant CHT prolongs radiotherapy overall treatment time (OTT) and decreases treatment adherence during concomitant chemoradiotherapy. An adequate minimum dose coverage to PTV(T) is a predictive variable well related to outcome.
Conclusion: Our data do not substantially differ in terms of survival and toxicity outcomes from those reported in larger series of patients treated in countries with higher incidences of NPC. The T stage (TNM 2002 UICC classification) is predictive of DSS and OS. The GTV volume (T ± N) and an adequate minimum PTV(T) coverage dose (D95 %) were also identified as potential predictive variables. Sophisticated technologies of dose delivery (IMRT) with image-guided radiotherapy could help to obtain better minimum PTV(T) coverage dose with increased DFS; distant metastasis after treatment still remains an unresolved issue.
Keywords: Chemotherapy; Prognosis; Radiotherapy; Survival; Toxicity.
Similar articles
-
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Oncotarget. 2015 Nov 10;6(35):38381-97. doi: 10.18632/oncotarget.5420. Oncotarget. 2015. PMID: 26485757 Free PMC article.
-
The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28. Cancer Res Treat. 2016. PMID: 26727716 Free PMC article.
-
Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.Radiother Oncol. 2014 Jul;112(1):106-11. doi: 10.1016/j.radonc.2014.05.005. Epub 2014 Jun 2. Radiother Oncol. 2014. PMID: 24933452
-
IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14. Strahlenther Onkol. 2016. PMID: 26972085 Review. English.
-
Diffusion-weighted MRI for predicting treatment response in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.Sci Rep. 2021 Sep 23;11(1):18986. doi: 10.1038/s41598-021-98508-5. Sci Rep. 2021. PMID: 34556743 Free PMC article.
Cited by
-
Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance.Asian Pac J Cancer Prev. 2020 May 1;21(5):1399-1407. doi: 10.31557/APJCP.2020.21.5.1399. Asian Pac J Cancer Prev. 2020. PMID: 32458648 Free PMC article.
-
Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma.Strahlenther Onkol. 2019 Jun;195(6):457-467. doi: 10.1007/s00066-018-01421-6. Epub 2019 Jan 28. Strahlenther Onkol. 2019. PMID: 30689027 English.
-
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.Br J Radiol. 2019 Oct;92(1102):20190068. doi: 10.1259/bjr.20190068. Epub 2019 May 31. Br J Radiol. 2019. PMID: 31150279 Free PMC article. Review.
-
Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.Front Oncol. 2020 Jun 12;10:930. doi: 10.3389/fonc.2020.00930. eCollection 2020. Front Oncol. 2020. PMID: 32596155 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources